Breast cancer draining to bilateral axillary sentinel lymph nodes

Surgery

Volumn 134, Issue 3, 2003, Pages 506-508

  Allweis, Tanir M ^a   Parson, Benjamin ^a   Klein, Martine ^a   Sklair Levy, Miri ^a   Maly, B ^a   Rivkind, Avraham ^a   Uziely, Beatrice ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; NANOCOLL; NANOCOLL TC 99M;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TREATMENT OUTCOME;

EID: 0141593467     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0039-6060(03)00247-2     Document Type: Article

References (5)

1. Jansen L, Doting MH, Rutgers EJ, de Vries J, Olmos RA, Nieweg OE. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000;87:920-5.
2. Tanis PJ, Nieweg OE, Valdes Olmos RA, Peterse JL, Rutgers EJ, Hoefnagel CA, Kroon BB. Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 2002;87:705-10.
3. Osborne MP. Breast anatomy and development. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000. p. 1-15.
4. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-36.
5. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 2002;195:467-75.